Published in Curr Diab Rep on February 01, 2005
Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins. Am J Physiol Endocrinol Metab (2006) 3.04
Cardiac remodeling in obesity. Physiol Rev (2008) 2.95
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomics (2009) 2.36
Exercise as a mean to control low-grade systemic inflammation. Mediators Inflamm (2009) 2.09
Obesity, inflammation, and liver cancer. J Hepatol (2011) 2.09
Voluntary exercise improves insulin sensitivity and adipose tissue inflammation in diet-induced obese mice. Am J Physiol Endocrinol Metab (2008) 1.96
Effects of caloric restriction on inflammatory periodontal disease. Nutrition (2008) 1.43
BMI and headache among women: results from 11 epidemiologic datasets. Obesity (Silver Spring) (2008) 1.24
Obesity and vascular dysfunction. Pathophysiology (2008) 1.23
Body mass index and adult weight gain among reproductive age women with migraine. Headache (2011) 1.17
Systemic inflammation and the metabolic syndrome among middle-aged community volunteers. Metabolism (2010) 1.16
Plasma YKL-40: a BMI-independent marker of type 2 diabetes. Diabetes (2008) 1.14
Metabolic Evidence of Diminished Lipid Oxidation in Women With Polycystic Ovary Syndrome. Curr Metabolomics (2014) 0.99
Dietary fatty acids differentially regulate production of TNF-alpha and IL-10 by murine 3T3-L1 adipocytes. Obesity (Silver Spring) (2008) 0.98
Early growth response protein-1 mediates lipotoxicity-associated placental inflammation: role in maternal obesity. Am J Physiol Endocrinol Metab (2013) 0.96
MCP-1 upregulates amylin expression in murine pancreatic β cells through ERK/JNK-AP1 and NF-κB related signaling pathways independent of CCR2. PLoS One (2011) 0.96
The central role of calcium in the effects of cytokines on beta-cell function: implications for type 1 and type 2 diabetes. Cell Calcium (2011) 0.95
Effect of marine-derived n-3 polyunsaturated fatty acids on C-reactive protein, interleukin 6 and tumor necrosis factor α: a meta-analysis. PLoS One (2014) 0.92
Prevalence of overweight and obesity and their cardiometabolic comorbidities in Hispanic adults living in Puerto Rico. J Community Health (2013) 0.91
A protective strategy against hyperinflammatory responses requiring the nontranscriptional actions of GPS2. Mol Cell (2012) 0.90
Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. World J Gastroenterol (2014) 0.89
Oral health behaviors and metabolic syndrome: the 2008-2010 Korean National Health and Nutrition Examination Survey. Clin Oral Investig (2013) 0.88
Effect of obesity and decompressive laparotomy on mortality in acute pancreatitis requiring intensive care unit admission. World J Surg (2013) 0.88
Excessive food intake, obesity and inflammation process in Zucker fa/fa rat pancreatic islets. PLoS One (2011) 0.88
The role of 25-hydroxyvitamin D deficiency in promoting insulin resistance and inflammation in patients with chronic kidney disease: a randomised controlled trial. BMC Nephrol (2009) 0.87
The efficacy of probiotics for monosodium glutamate-induced obesity: dietology concerns and opportunities for prevention. EPMA J (2014) 0.87
Alzheimer's disease and type 2 diabetes: multiple mechanisms contribute to interactions. Curr Diab Rep (2014) 0.86
Lifetime prevalence and correlates of migraine among women in a pacific northwest pregnancy cohort study. Headache (2013) 0.85
The prevalence of primary headache disorders and their associated factors among nursing staff in North China. J Headache Pain (2015) 0.84
Influence of obesity on the severity and clinical outcome of acute pancreatitis. Gut Liver (2011) 0.84
Hematological indices and their correlation with fasting blood glucose level and anthropometric measurements in type 2 diabetes mellitus patients in Gondar, Northwest Ethiopia. Diabetes Metab Syndr Obes (2016) 0.83
Three types of scientific evidence to inform physical activity policy: results from a comparative scoping review. Int J Public Health (2016) 0.83
Morbid Obesity Is Associated With Adverse Clinical Outcomes in Acute Pancreatitis: A Propensity-Matched Study. Am J Gastroenterol (2015) 0.83
Distribution and correlates of the metabolic syndrome in adults living in the San Juan Metropolitan Area of Puerto Rico. P R Health Sci J (2012) 0.82
Octreotide alleviates obesity by reducing intestinal glucose absorption and inhibiting low-grade inflammation. Eur J Nutr (2012) 0.82
Protective role of macrophage migration inhibitory factor in nonalcoholic steatohepatitis. FASEB J (2014) 0.81
Anti-inflammatory nutrition as a pharmacological approach to treat obesity. J Obes (2010) 0.80
The 14 bp Del/Ins HLA-G polymorphism is related with high blood pressure in acute coronary syndrome and type 2 diabetes mellitus. Biomed Res Int (2014) 0.79
Impaired preadipocyte differentiation into adipocytes in subcutaneous abdominal adipose of PCOS-like female rhesus monkeys. Endocrinology (2014) 0.79
Developmental Programming: Impact of Gestational Steroid and Metabolic Milieus on Adiposity and Insulin Sensitivity in Prenatal Testosterone-Treated Female Sheep. Endocrinology (2015) 0.78
Association of cholecystectomy with metabolic syndrome in a Chinese population. PLoS One (2014) 0.78
Platelet counts and liver enzymes after bariatric surgery. J Obes (2013) 0.78
Considerations for Defining Cytokine Dose, Duration, and Milieu That Are Appropriate for Modeling Chronic Low-Grade Inflammation in Type 2 Diabetes. J Diabetes Res (2016) 0.77
Metabolic syndrome and colorectal cancer: is hyperinsulinemia/insulin receptor-mediated angiogenesis a critical process? J Geriatr Oncol (2013) 0.77
Changes in erythrocyte sedimentation rate, white blood cell count, liver enzymes, and magnesium after gastric bypass surgery. J Obes (2011) 0.77
Implementation of the Asia-Pacific guidelines of obesity classification on the APACHE-O scoring system and its role in the prediction of outcomes of acute pancreatitis: a study from India. Dig Dis Sci (2013) 0.77
Personality Correlates of Midlife Cardiometabolic Risk: The Explanatory Role of Higher-Order Factors of the Five-Factor Model. J Pers (2015) 0.76
The relationship between red blood cell distribution width and blood pressure in patients with type 2 diabetes mellitus in Lagos, Nigeria. J Blood Med (2014) 0.76
Prokineticin-2 is associated with metabolic syndrome in a middle-aged and elderly Chinese population. Lipids Health Dis (2016) 0.75
Resistin is not an appropriate biochemical marker to predict severity of acute pancreatitis: a case-controlled study. World J Gastroenterol (2014) 0.75
High Hydrostatic Pressure Extract of Red Ginseng Attenuates Inflammation in Rats with High-fat Diet Induced Obesity. Prev Nutr Food Sci (2015) 0.75
K-111: the emerging evidence for its potential in the treatment of the metabolic syndrome. Core Evid (2006) 0.75
The effects of Jiao-Tai-Wan on sleep, inflammation and insulin resistance in obesity-resistant rats with chronic partial sleep deprivation. BMC Complement Altern Med (2017) 0.75
The metabolic syndrome: what's in a name? Ther Adv Endocrinol Metab (2010) 0.75
Age and sex dependent effects of early overnutrition on metabolic parameters and the role of neonatal androgens. Biol Sex Differ (2016) 0.75
Obesity as a risk factor for severe acute pancreatitis patients. Wien Klin Wochenschr (2014) 0.75
Diabetes in older adults: a consensus report. J Am Geriatr Soc (2012) 3.63
Diabetes in older adults. Diabetes Care (2012) 3.62
High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes (2002) 2.98
Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation. J Allergy Clin Immunol (2011) 2.53
High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes (2002) 2.36
An official American Thoracic Society Workshop report: obesity and asthma. Proc Am Thorac Soc (2010) 2.05
Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Circulation (2011) 1.81
Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians. Atherosclerosis (2002) 1.60
Does addition of sitagliptin to metformin monotherapy improve glycemic control in patients with type 2 diabetes mellitus? Nat Clin Pract Endocrinol Metab (2007) 1.29
Obesity and asthma: an inflammatory disease of adipose tissue not the airway. Am J Respir Crit Care Med (2012) 1.28
Sex differences in the human brain's response to hunger and satiation. Am J Clin Nutr (2002) 1.25
Taste preferences and body weight changes in an obesity-prone population. Am J Clin Nutr (2004) 1.17
Treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin improves fasting islet-cell function in subjects with type 2 diabetes. J Clin Endocrinol Metab (2008) 1.09
Amyloid precursor protein expression is upregulated in adipocytes in obesity. Obesity (Silver Spring) (2008) 1.00
Comparison of the efficacy and tolerability profile of liraglutide, a once-daily human GLP-1 analog, in patients with type 2 diabetes ≥65 and <65 years of age: a pooled analysis from phase III studies. Am J Geriatr Pharmacother (2011) 0.97
Ezetimibe/simvastatin or atorvastatin for the treatment of hypercholesterolemia in patients with the metabolic syndrome: the VYMET study. Curr Diab Rep (2010) 0.96
Plasma amyloid-beta peptide levels correlate with adipocyte amyloid precursor protein gene expression in obese individuals. Neuroendocrinology (2009) 0.96
Adipose tissue dysfunction in polycystic ovary syndrome. Curr Diab Rep (2011) 0.95
Effect of ovarian suppression with gonadotropin-releasing hormone agonist on glucose disposal and insulin secretion. Am J Physiol Endocrinol Metab (2008) 0.95
Sexually dimorphic diet-induced insulin resistance in obese tissue inhibitor of metalloproteinase-2 (TIMP-2)-deficient mice. Endocrinology (2011) 0.90
The cannabinoid CB1 receptor is expressed in pancreatic delta-cells. Biochem Biophys Res Commun (2008) 0.90
Efficacy and safety of incretin-based therapies in patients with type 2 diabetes mellitus. Am J Med (2009) 0.90
Clinical measures of islet function: usefulness to characterize defects in diabetes. Curr Diabetes Rev (2008) 0.90
Advances in the treatment of prediabetes. Ther Adv Endocrinol Metab (2010) 0.89
Central and peripheral endocannabinoids and cognate acylethanolamides in humans: association with race, adiposity, and energy expenditure. J Clin Endocrinol Metab (2010) 0.86
Measurement of altered AβPP isoform expression in frontal cortex of patients with Alzheimer's disease by absolute quantification real-time PCR. J Alzheimers Dis (2012) 0.85
Endogenous glucose production, insulin sensitivity, and insulin secretion in normal glucose-tolerant Pima Indians with low birth weight. Metabolism (2004) 0.84
Beta-cell function in mild type 2 diabetic patients: effects of 6-month glucose lowering with nateglinide. Diabetes Care (2005) 0.83
Sweet taste receptors regulate basal insulin secretion and contribute to compensatory insulin hypersecretion during the development of diabetes in male mice. Endocrinology (2014) 0.83
The impact of diabetes and diabetes medications on bone health. Endocr Rev (2015) 0.82
Insulin resistance increases PAI-1 in the heart. Biochem Biophys Res Commun (2006) 0.82
Associations of fatty acids in cerebrospinal fluid with peripheral glucose concentrations and energy metabolism. PLoS One (2012) 0.82
Increased plasminogen activator inhibitor type-1 (PAI-1) in the heart as a function of age. Life Sci (2006) 0.81
Efficacy and safety of incretin-based therapies in patients with type 2 diabetes mellitus. Eur J Intern Med (2009) 0.81
GIP: an inconsequential incretin or not? Diabetes Care (2010) 0.80
Liraglutide achieves A1C targets more often than sitagliptin or exenatide when added to metformin in patients with type 2 diabetes and a baseline A1C <8.0%. Endocr Pract (2013) 0.80
Abdominal obesity and cardiovascular disease risk: the emerging role of the adipocyte. J Cardiopulm Rehabil Prev (2007) 0.80
The PROactive Study: pioglitazone in the secondary prevention of macrovascular events in patients with type 2 diabetes. Curr Diab Rep (2006) 0.80
COMPARISON OF THE LONG-TERM EFFECTS OF LIRAGLUTIDE AND GLIMEPIRIDE MONOTHERAPY ON BONE MINERAL DENSITY IN PATIENTS WITH TYPE 2 DIABETES. Endocr Pract (2015) 0.78
UCP5/BMCP1 transcript isoforms in human skeletal muscle: relationship of the short-insert isoform with lipid oxidation and resting metabolic rates. Mol Genet Metab (2002) 0.77
Efficacy of antihyperglycemic therapies and the influence of baseline hemoglobin A(1C): a meta-analysis of the liraglutide development program. Endocr Pract (2011) 0.77
The quality of fat in the diet and its impact on insulin sensitivity. Curr Diab Rep (2002) 0.76
Does the metabolic syndrome carry additional risk for myocardial infarction? Curr Diab Rep (2011) 0.75
Effects of improving insulin sensitivity on nontraditional cardiovascular risk factors in patients with type 2 diabetes. Curr Diab Rep (2003) 0.75
Beta-cell preservation…Is weight loss the answer? Rev Diabet Stud (2012) 0.75
LAP-BAND or medical therapy for metabolic syndrome? Curr Diab Rep (2008) 0.75
Weight loss and diets: which diet works best? Curr Diab Rep (2009) 0.75
The DREAM Trial: using ramipril and rosiglitazone to prevent diabetes. Curr Diab Rep (2007) 0.75
On rendering continuous glucose monitoring ready for prime time in the cardiac care unit. Coron Artery Dis (2007) 0.75
Type 2 diabetes is one of the leading causes of premature morbidity and mortality. Introduction. Am J Med (2013) 0.75